| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8684065 | Epilepsy Research | 2018 | 20 Pages |
Abstract
The results show that the KD can reduce the species richness and diversity of intestinal microbiota. The changes of gut microbiota may be associated with different efficacy after KD, and specific gut microbiota may serve as an efficacy biomarker and a potential therapeutic target in patients with refractory epilepsy.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Yunjian Zhang, Shuizhen Zhou, Yuanfeng Zhou, Lifei Yu, Linmei Zhang, Yi Wang,